Patents by Inventor Arash Raoufinia

Arash Raoufinia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Once daily formulations of tetracyclines
    Patent number: 7749532
    Abstract: Disclosed are once-daily formulations containing tetracyclines, especially doxycycline. Such formulations are useful, for instance, for the treatment of collagenase destructive enzyme-dependent diseases, such as periodontal disease and acne, and acute and chronic inflammatory disease states, such as rosacea and arthritis.
    Type: Grant
    Filed: April 7, 2004
    Date of Patent: July 6, 2010
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Rong-Kun Chang, Arash Raoufinia, Niraj Shah
  • Once daily formulations of tetracyclines
    Publication number: 20090011006
    Abstract: Disclosed are once-daily formulations containing tetracyclines, especially doxycycline. Such formulations are useful, for instance, for the treatment of collagenase destructive enzyme-dependent diseases, such as periodontal disease and acne, and acute and chronic inflammatory disease states, such as rosacea and arthritis.
    Type: Application
    Filed: June 6, 2008
    Publication date: January 8, 2009
    Inventors: Rong-Kun Chang, Arash Raoufinia, Niraj Shah
  • Once daily dosage forms of trospium
    Publication number: 20080207664
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Application
    Filed: August 17, 2007
    Publication date: August 28, 2008
    Applicant: SUPERNUS PHARMACEUTICALS, INC.
    Inventors: Argaw Kidane, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia
  • Once daily dosage forms of trospium
    Publication number: 20080207663
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Application
    Filed: August 17, 2007
    Publication date: August 28, 2008
    Applicant: SUPERNUS PHARMACEUTICALS, INC.
    Inventors: Argaw Kidane, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia
  • Once daily dosage forms of trospium
    Publication number: 20080207662
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Application
    Filed: August 17, 2007
    Publication date: August 28, 2008
    Applicant: SUPERNUS PHARMACEUTICALS, INC.
    Inventors: Argaw Kidane, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia
  • Once daily dosage forms of trospium
    Publication number: 20080207661
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Application
    Filed: August 17, 2007
    Publication date: August 28, 2008
    Applicant: SUPERNUS PHARMACEUTICALS, INC.
    Inventors: Argaw Kidane, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia
  • Once daily dosage forms of trospium
    Patent number: 7410978
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Grant
    Filed: November 4, 2004
    Date of Patent: August 12, 2008
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventors: Argaw Kidane, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia
  • Once daily dosage forms of trospium
    Publication number: 20050191351
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Application
    Filed: November 4, 2004
    Publication date: September 1, 2005
    Applicant: Shire Laboratories, Inc.
    Inventors: Argaw Kidane, Henry Flanner, Padmanabh Bhatt, Arash Raoufinia
  • Once daily formulations of tetracyclines
    Publication number: 20040228912
    Abstract: Disclosed are once-daily formulations containing tetracyclines, especially doxycycline. Such formulations are useful, for instance, for the treatment of collagenase destructive enzyme-dependent diseases, such as periodontal disease and acne, and acute and chronic inflammatory disease states, such as rosacea and arthritis.
    Type: Application
    Filed: April 7, 2004
    Publication date: November 18, 2004
    Inventors: Rong-Kun Chang, Arash Raoufinia, Niraj Shah